戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 (LAC), through on-chip electrical sensing of bacterial lysate.
2 onstrated by the direct detection of rRNA in bacterial lysate.
3 plying a coumarin-based fluorogenic probe in bacterial lysates.
4              We purified these proteins from bacterial lysates.
5 ot by normal HeLa cell lysates or irrelevant bacterial lysates.
6 both native and recombinant SodA activity in bacterial lysates.
7  as GST fusion proteins, to homogeneity from bacterial lysates.
8 was partially degraded during isolation from bacterial lysates.
9 specific electrophoretic patterns from crude bacterial lysates.
10 ering surfaces amplify chemical signals from bacterial lysate and rapidly generate large, reproducibl
11  to extract and focus 16S rRNA directly from bacterial lysate and used molecular beacons to achieve d
12 binds H-Ras.GTP in both pulldown assays from bacterial lysates and by coimmunoprecipitation from HEK2
13    All 13 fusion proteins were purified from bacterial lysates and used to test a panel of anti-HCV p
14 rformance was verified with model samples of bacterial lysates and with four real-matrix samples of k
15          We sought to evaluate the effect of bacterial lysate applied orally from the second until se
16 ells are completely lyzed, and the resulting bacterial lysates are thoroughly mixed with the potassiu
17 sponding to whole Gram-negative bacteria and bacterial lysates, as demonstrated by NF-kappaB activati
18 revention of AD by oral supplementation of a bacterial lysate between week 5 and the end of month 7,
19            The protein was purified from the bacterial lysate by affinity chromatography using a biot
20  recapitulate the protection afforded by the bacterial lysate by stimulating the lung epithelium with
21 00Z protein was purified to homogeneity from bacterial lysates by a combination of hydrophobic column
22         The fusion protein was purified from bacterial lysates by affinity chromatography with an amy
23  least one allergic parent received orally a bacterial lysate consisting of heat-killed Gram-negative
24                            When exposed to a bacterial lysate containing estrogen receptor alpha liga
25 of month 7, infants were treated orally with bacterial lysate containing heat-killed gram-negative Es
26 ture of purified rabbit hsp90 and hsp70 with bacterial lysate containing human p60 results in spontan
27         The assay is sensitive enough to use bacterial lysates diluted 20 fold.
28  EIA with the current serodiagnostic test, a bacterial lysate EIA, revealed relatively good correlati
29  A new approach to the isolation of RNA from bacterial lysates employs selective precipitation by com
30           Expression of epitope-tagged S3 in bacterial lysates followed by photoaffinity labeling con
31 ous non-helicobacter bacteria, or with cecal bacterial lysate from uninfected mice.
32 noglobulin M (IgM) and IgA established using bacterial lysates from homologous (the infecting strain)
33 ght to evaluate the effect of orally applied bacterial lysate in infancy on the prevalence of atopic
34                                        Using bacterial lysates in dot blot analysis, a panel of sera
35 e use of prebiotics, probiotic bacteria, and bacterial lysates in early life, this review provides an
36  The effect of H. pylori recombinant urease, bacterial lysate, intact bacteria, and bacterial DNA on
37 ntify proteins and other molecules in single bacterial lysates is encouraging to use the new analysis
38 BFP is a different protein again, and in the bacterial lysate it occurs in multiple forms, ligated to
39 yses demonstrated that, compared to standard bacterial lysates, MAV was enriched with Hsps and contai
40                                   Feeding of bacterial lysate might have prevented the development of
41                                      An oral bacterial lysate of heat-killed Gram-negative Escherichi
42 tibody bound to recombinant SREHP present in bacterial lysates on immunoblots.
43  cell production of IFN-gamma in response to bacterial lysate or LPS was Ag independent and could be
44 te IFN-gamma in response to stimulation with bacterial lysate or LPS.
45 r treated animals with H. pylori components (bacterial lysate or the immunomodulator VacA) and subseq
46 dal lymph node CD4 + T cells stimulated with bacterial lysate-pulsed antigen-presenting cells.
47 stitution of germfree RAG-/- mice with cecal bacterial lysate-pulsed DCs, but not with IL-6-/- or Myd
48 d serum IgG and IgE antibody levels to whole bacterial lysate, recombinant P1 adhesin, and OVA.
49 nylation or by Western blotting of the whole bacterial lysate, suggesting that it is not expressed by
50 e induced therapeutically by inhalation of a bacterial lysate that protects mice against otherwise le
51 onstration that administering a standardized bacterial lysate to the airway compartment protects from
52 n (through pre-, pro-, syn- and postbiotics, bacterial lysates, vaccinations, and monoclonal antibodi
53                            The aqueous phase bacterial lysate was isolated in an array of microwells,
54 Ns into Escherichia coli expression vectors, bacterial lysates were found to be most suitable for in
55                                              Bacterial lysates were probed by using Western blot anal